Growth Metrics

Opus Genetics (IRD) Return on Sales (2022 - 2024)

Opus Genetics (IRD) has disclosed Return on Sales for 2 consecutive years, with 583.2% as the latest value for Q1 2011.

  • On a quarterly basis, Return on Sales changed N/A to 583.2% in Q1 2011 year-over-year; TTM through Mar 2011 was 583.2%, a N/A change, with the full-year FY2022 number at 0.45%, up 9670.0% from a year prior.
  • Return on Sales was 583.2% for Q1 2011 at Opus Genetics, down from 191.84% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 191.84% in Q2 2010 to a low of 583.2% in Q1 2011.